{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:06:04Z","timestamp":1790744764105,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-15-CE17-0005-01"],"award-info":[{"award-number":["ANR-15-CE17-0005-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytical Biochemistry"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ab.2017.12.029","type":"journal-article","created":{"date-parts":[[2017,12,25]],"date-time":"2017-12-25T10:04:34Z","timestamp":1514196274000},"page":"114-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Colorimetric immunoassays for the screening and specificity evaluation of molecules disturbing VEGFs\/VEGFRs interactions"],"prefix":"10.1016","volume":"544","author":[{"given":"Laura","family":"Trapiella-Alfonso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3098-5317","authenticated-orcid":false,"given":"Sylvain","family":"Broussy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang-Qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Lecarpentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilis","family":"Tsatsaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0185-2080","authenticated-orcid":false,"given":"Nathalie","family":"Gagey-Eilstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6626","key":"10.1016\/j.ab.2017.12.029_bib1","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/386671a0","article-title":"Mechanisms of angiogenesis","volume":"386","author":"Risau","year":"1997","journal-title":"Nature"},{"issue":"7347","key":"10.1016\/j.ab.2017.12.029_bib2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"issue":"7070","key":"10.1016\/j.ab.2017.12.029_bib3","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature04483","article-title":"Angiogenesis as a therapeutic target","volume":"438","author":"Ferrara","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ab.2017.12.029_bib4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev-cellbio-092910-154002","article-title":"Developmental and pathological angiogenesis","volume":"27","author":"Chung","year":"2011","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"Suppl 3","key":"10.1016\/j.ab.2017.12.029_bib5","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1186\/ar575","article-title":"Angiogenesis in rheumatoid arthritis","volume":"4","author":"Paleolog","year":"2002","journal-title":"Arthritis Res."},{"issue":"3","key":"10.1016\/j.ab.2017.12.029_bib6","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1365-2613.2009.00669.x","article-title":"Angiogenesis drives psoriasis pathogenesis","volume":"90","author":"Heidenreich","year":"2009","journal-title":"Int. J. Exp. Pathol."},{"issue":"4","key":"10.1016\/j.ab.2017.12.029_bib7","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/pr.56.4.3","article-title":"Vascular endothelial growth factor and angiogenesis","volume":"56","author":"Hoeben","year":"2004","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.ab.2017.12.029_bib8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.str.2016.12.012","article-title":"Structure of the full-length VEGFR-1 extracellular domain in complex with VEGF-A","volume":"25","author":"Markovic-Mueller","year":"2017","journal-title":"Structure"},{"issue":"31","key":"10.1016\/j.ab.2017.12.029_bib9","doi-asserted-by":"crossref","first-page":"23779","DOI":"10.1074\/jbc.M110.130658","article-title":"Structural insights into the binding of vascular endothelial growth Factor-B by VEGFR-1(D2)","volume":"285","author":"Iyer","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.ab.2017.12.029_bib10","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1182\/blood-2011-11-390922","article-title":"Thermodynamic and structural description of allosterically regulated VEGFR-2 dimerization","volume":"119","author":"Brozzo","year":"2012","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.ab.2017.12.029_bib11","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc2403","article-title":"VEGF-targeted therapy: mechanisms of anti-tumour activity","volume":"8","author":"Ellis","year":"2008","journal-title":"Nat. Rev. Canc."},{"issue":"S4","key":"10.1016\/j.ab.2017.12.029_bib12","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/cncr.24789","article-title":"Vascular endothelial growth factor receptor-1 in human cancer","volume":"116","author":"Schwartz","year":"2010","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.ab.2017.12.029_bib13","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1158\/1078-0432.CCR-04-1564","article-title":"Anti-Flt1 peptide, a vascular endothelial growth factor receptor 1\u2013specific hexapeptide, inhibits tumor growth and metastasis","volume":"11","author":"Bae","year":"2005","journal-title":"Clin. Canc. Res."},{"issue":"21","key":"10.1016\/j.ab.2017.12.029_bib14","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.1158\/1078-0432.CCR-06-0831","article-title":"Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer","volume":"12","author":"Wu","year":"2006","journal-title":"Clin. Cancer. Res."},{"issue":"3","key":"10.1016\/j.ab.2017.12.029_bib15","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cell.2007.08.038","article-title":"Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels","volume":"131","author":"Fischer","year":"2007","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ab.2017.12.029_bib16","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1158\/1535-7163.MCT-06-0461","article-title":"Role of placenta growth factor in malignancy and evidence that an antagonistic PlGF\/Flt-1 peptide inhibits the growth and metastasis of human breast cancer xenografts","volume":"6","author":"Taylor","year":"2007","journal-title":"Mol. Canc. Therapeut."},{"issue":"6","key":"10.1016\/j.ab.2017.12.029_bib17","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.survophthal.2016.03.010","article-title":"Vascular endothelial growth factor and diabetic macular edema","volume":"61","author":"Lally","year":"2016","journal-title":"Surv. Ophthalmol."},{"issue":"22","key":"10.1016\/j.ab.2017.12.029_bib18","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders","volume":"331","author":"Aiello","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ab.2017.12.029_bib19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1874364101307010004","article-title":"Diabetic retinopathy and VEGF","volume":"7","author":"Gupta","year":"2013","journal-title":"Open Ophthalmol. J."},{"issue":"2","key":"10.1016\/j.ab.2017.12.029_bib20","doi-asserted-by":"crossref","first-page":"c72","DOI":"10.1159\/000101801","article-title":"Pre-eclampsia: clinical manifestations and molecular mechanisms","volume":"106","author":"Baumwell","year":"2007","journal-title":"Nephron Clin. Pract."},{"key":"10.1016\/j.ab.2017.12.029_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev.med.59.110106.214058","article-title":"Preeclampsia and angiogenic imbalance","volume":"59","author":"Maynard","year":"2008","journal-title":"Annu. Rev. Med."},{"issue":"7290","key":"10.1016\/j.ab.2017.12.029_bib22","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature08945","article-title":"Vascular endothelial growth factor B controls endothelial fatty acid uptake","volume":"464","author":"Hagberg","year":"2010","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ab.2017.12.029_bib23","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/jdi.12099","article-title":"Vascular endothelial growth factor-B as a therapeutic target to prevent ectopic fat deposition","volume":"4","author":"Hosooka","year":"2013","journal-title":"J. Diabetes Investig."},{"issue":"7420","key":"10.1016\/j.ab.2017.12.029_bib24","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nature11464","article-title":"Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes","volume":"490","author":"Hagberg","year":"2012","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.ab.2017.12.029_bib25","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/cr.2010.77","article-title":"VEGF-B: A thing of beauty","volume":"20","author":"Li","year":"2010","journal-title":"Cell Res."},{"issue":"6\u20137","key":"10.1016\/j.ab.2017.12.029_bib26","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/minf.201400040","article-title":"Drug-like protein\u2013protein interaction modulators: challenges and opportunities for drug discovery and chemical biology","volume":"33","author":"Villoutreix","year":"2014","journal-title":"Mol. Inform."},{"issue":"33","key":"10.1016\/j.ab.2017.12.029_bib27","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1021\/acs.biochem.5b00722","article-title":"Vascular endothelial growth factor peptide ligands explored by competition assay and isothermal titration calorimetry","volume":"54","author":"Reille-Seroussi","year":"2015","journal-title":"Biochemistry"},{"issue":"51","key":"10.1016\/j.ab.2017.12.029_bib28","doi-asserted-by":"crossref","first-page":"17754","DOI":"10.1021\/bi981931e","article-title":"Novel peptides selected to bind vascular endothelial growth factor target the receptor-binding site","volume":"37","author":"Fairbrother","year":"1998","journal-title":"Biochemistry"},{"issue":"11","key":"10.1016\/j.ab.2017.12.029_bib29","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1039\/c3ob27312a","article-title":"Helical peptides from VEGF and Vammin hotspots for modulating the VEGF\u2013VEGFR interaction","volume":"11","author":"Garc\u00eda-Aranda","year":"2013","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ab.2017.12.029_bib30","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.chembiol.2011.10.016","article-title":"Targeting the proangiogenic VEGF-VEGFR protein-protein interface with drug-like compounds by in silico and in vitro screening","volume":"18","author":"Gautier","year":"2011","journal-title":"Chem. Biol."},{"issue":"40","key":"10.1016\/j.ab.2017.12.029_bib31","doi-asserted-by":"crossref","first-page":"14215","DOI":"10.1073\/pnas.0505047102","article-title":"Targeting angiogenesis: structural characterization and biological properties of a de novo engineered VEGF mimicking peptide","volume":"102","author":"D'Andrea","year":"2005","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/j.ab.2017.12.029_bib32","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ab.2008.03.043","article-title":"A fluorescence polarization assay for identifying ligands that bind to vascular endothelial growth factor","volume":"378","author":"Peterson","year":"2008","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.ab.2017.12.029_bib33","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ab.2007.03.027","article-title":"Development of a chemiluminescent screening assay for detection of vascular endothelial growth factor receptor 1 ligands","volume":"366","author":"Goncalves","year":"2007","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ab.2017.12.029_bib34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ab.2017.05.004","article-title":"VEGFR1 domain 2 covalent labeling with horseradish peroxidase: development of a displacement assay on VEGF","volume":"530","author":"Reille-Seroussi","year":"2017","journal-title":"Anal. Biochem."},{"issue":"15","key":"10.1016\/j.ab.2017.12.029_bib35","doi-asserted-by":"crossref","first-page":"6598","DOI":"10.1021\/acs.jmedchem.7b00283","article-title":"Identification of peptidic antagonists of vascular endothelial growth factor receptor-1 by scanning the binding epitopes of its ligands","volume":"60","author":"Wang","year":"2017","journal-title":"J. Med. Chem."},{"issue":"23","key":"10.1016\/j.ab.2017.12.029_bib36","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Yung-Chi","year":"1973","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.ab.2017.12.029_bib37","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0026-895X(25)08761-9","article-title":"Interpretation of binding curves obtained with high receptor concentrations: practical aid for computer analysis","volume":"47","author":"Swillens","year":"1995","journal-title":"Mol. Pharmacol."},{"issue":"6","key":"10.1016\/j.ab.2017.12.029_bib38","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/j.1476-5381.2009.00604.x","article-title":"Ligand binding assays at equilibrium: validation and interpretation","volume":"161","author":"Hulme","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.ab.2017.12.029_bib39","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1177\/1947601911423031","article-title":"Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies","volume":"2","author":"Shibuya","year":"2011","journal-title":"Genes Cancer"},{"issue":"2","key":"10.1016\/j.ab.2017.12.029_bib40","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10456-011-9249-6","article-title":"Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab","volume":"15","author":"Papadopoulos","year":"2012","journal-title":"Angiogenesis"},{"issue":"5","key":"10.1016\/j.ab.2017.12.029_bib41","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1182\/blood-2010-08-301549","article-title":"Structural determinants of vascular endothelial growth factor-D receptor binding and specificity","volume":"117","author":"Lepp\u00e4nen","year":"2011","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.ab.2017.12.029_bib42","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1046\/j.1440-1681.2002.03769.x","article-title":"Human vascular endothelial growth factor B: characterization of recombinant isoforms and generation of neutralizing monoclonal antibodies","volume":"29","author":"Scotney","year":"2002","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"2","key":"10.1016\/j.ab.2017.12.029_bib43","first-page":"213","article-title":"Flt-1 but not KDR\/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor","volume":"7","author":"Sawano","year":"1996","journal-title":"Cell Growth Differ."},{"issue":"12","key":"10.1016\/j.ab.2017.12.029_bib44","doi-asserted-by":"crossref","first-page":"e0167755","DOI":"10.1371\/journal.pone.0167755","article-title":"Biophysical studies of the induced dimerization of human VEGF receptor 1 binding domain by divalent metals competing with VEGF-A","volume":"11","author":"Gaucher","year":"2016","journal-title":"PLoS One"},{"issue":"22","key":"10.1016\/j.ab.2017.12.029_bib45","doi-asserted-by":"crossref","first-page":"19166","DOI":"10.1074\/jbc.M100097200","article-title":"The specificity of receptor binding by vascular endothelial growth factor-D is different in mouse and man","volume":"276","author":"Baldwin","year":"2001","journal-title":"J. Biol. Chem."}],"container-title":["Analytical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269717305420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269717305420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T21:21:54Z","timestamp":1757712114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003269717305420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":45,"alternative-id":["S0003269717305420"],"URL":"https:\/\/doi.org\/10.1016\/j.ab.2017.12.029","relation":{},"ISSN":["0003-2697"],"issn-type":[{"value":"0003-2697","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Colorimetric immunoassays for the screening and specificity evaluation of molecules disturbing VEGFs\/VEGFRs interactions","name":"articletitle","label":"Article Title"},{"value":"Analytical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ab.2017.12.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}